Supported by National Key Research and Development Program,No.2022YFA1104401;Beijing Natural Science Foundation,No.7222075;CAMS Innovation Fund for Medical Sciences,No.2019RU020;Innovation Research Team Project of Beijing Stomatological Hospital,No.CXTD202204.
BACKGROUND Stem cells from apical papilla(SCAPs)represent promising candidates for bone regenerative therapies due to their osteogenic potential.However,enhancing their differentiation capacity remains a critical chal...
Hepatocellular carcinoma(HCC)is the third leading cause of cancer-related deaths worldwide.Major treatments include liver transplantation,resection,and chemotherapy,but the 5-year recurrence rate remains high.Late dia...
funded by the National Natural Science Foundation of China(No.81672573);Natural Science Foundation of Xinjiang Uygur Autonomous Region(No.2021D01F21);Natural Science Foundation of Hubei Province(No.2021CFB474)。
Objective:Histone modification has a significant effect on gene expression.Enhancer of zeste homolog 2(EZH2)contributes to the epigenetic silencing of target chromatin through its roles as a histone-lysine N-methyltra...
Supported by a grant from the Qingdao 2020 Medical Scientific Research Guidance Plan(No.2020-WJZD036).
Enhancer of zeste homolog 2(EZH2)is the catalytic subunit of polycomb repressive complex 2(PRC2).Dysregulation of EZH2 causes alteration of gene expression and functions,thereby promoting cancer development.Recent stu...
Supported by The Medical Science and Technology Key Project of Henan Province,No.2018020733.
BACKGROUND Diabetes is a chronic metabolic disease,and a variety of miRNA are involved in the occurrence and development of diabetes.In clinical studies,miR-124 is highly expressed in the serum of patients with diabet...
supported by the National Key R&D Program of China(2020YFC2005000);the National Natural Science Foundation of China(82070711);the Science/Technology Project of Sichuan province(2020YFQ0055);the 1.3.5 project for disciplines of excellence from West China Hospital of Sichuan University(ZYGD18027).
Enhancer of zeste homolog 2(EZH2),a component of polycomb repressive complex 2(PRC2),is a histone lysine methyltransferase mediating trimethylation of histone H3 at lysine 27(H3K27me3),which is a repressive marker at ...
Supported by National Natural Science Foundation of China,No.81900498.
BACKGROUND Inflammatory bowel disease(IBD)is a prevalent worldwide health problem featured by relapsing,chronic gastrointestinal inflammation.Enhancer of zeste homolog 2(EZH2)is a critical epigenetic regulator in diff...
OBJECTIVE Prostate cancer is the most commonly diagnosed malignancy and the sixth leading cause of cancer death in men.Aberrant upregulation of enhancer of Zeste homolog2(EZH2)occur frequently in human cancers,includi...
Polycomb group proteins represent a global silencing system involved in development regulation.In specific,they regulate the transition from proliferation to differentiation,contributing to stem-cell maintenance and i...